Roles of 5-HT3 and 5-HT7 receptors in acute pruriceptive processing in mice

• Published in: European journal of pharmacology 2021-11, Vol.911, p.174513, Article 174513
• Main Authors: Miyahara, Yu, Funahashi, Hideki, Haruta-Tsukamoto, Ayaka, Kogoh, Yoichiro, Kanemaru-Kawazoe, Anna, Nishimori, Toshikazu, Ishida, Yasushi
• Format: Article
• Language: English
• Subjects: 5-HT3 receptors; 5-HT7 receptors; Mouse; Pruritus; Scratching behavior
• ISSN: 0014-2999; 1879-0712; 1879-0712
• DOI: 10.1016/j.ejphar.2021.174513

The roles of serotonin (5-HT) and/or noradrenaline in acute pruriceptive processing have been demonstrated using antidepressants, such as milnacipran, a serotonin and noradrenaline reuptake inhibitor, and mirtazapine, a noradrenergic and specific serotonergic antidepressant; however, the involvement of 5-HT in acute pruriceptive processing has not yet been elucidated in detail. Scratching events induced by chloroquine (CQ) were attenuated by the administration of milnacipran or mirtazapine, and these effects were reversed by a treatment with ondansetron, a 5-HT3 antagonist, or SB26970, a 5-HT7 antagonist. CQ-induced scratching events were also ameliorated by the intrathecal administration of 5-HT, SR572227A and RS56812 (5-HT3 agonists), and LP211 and LP44 (5-HT7 agonists), indicating the modulation of CQ-induced scratching events by 5-HT and noradrenaline. By contrast, histamine-induced scratching events were not markedly affected by the administration of 5-HT and 5-HT7 agonists, whereas 5-HT3 agonists exerted attenuating effects. Similarly, they were not clearly reversed by the administration of the 5-HT7 antagonist, unlike a 5-HT3 antagonist. Therefore, 5-HT is involved in the attenuating effects of milnacipran and mirtazapine on CQ- and histamine-induced scratching events, and 5-HT3 and 5-HT7 receptors play different roles in pruriceptive processing induced by histamine or CQ. •Milnacipran and mirtazapine inhibit histamine-/chloroquine (CQ)-induced scratching.•An antagonist of 5-HT3 receptors reverses this inhibition.•A 5-HT7 antagonist reverses the inhibition of CQ-induced scratching.•5-HT and agonists of 5-HT3 and 5-HT7 receptors inhibit CQ-induced scratching.•5-HT3 agonists, but not 5-HT or 5-HT7 agonists, inhibit histamine-induced scratching.